ONKURE THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
ONKURE THERAPEUTICS, INC. (OKUR) reported Basic Shares Outstanding (Weighted Average) of 49.87 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 49.87M shares, a 269.15% increase year-over-year.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 13.67M shares, a 1.86% increase year-over-year.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 13.60M shares, a 5.88% increase year-over-year.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 13.53M shares, a 4180.00% increase year-over-year.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 13.52M shares, a 292.10% increase from fiscal 2024.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 3.45M shares, a 1114.54% increase from fiscal 2023.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 283.82K shares, a 98.84% decline from fiscal 2022.
- ONKURE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 24.50M shares, a 35.01% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 49.87M shares 10-Q · filed 2026-08-04 | 31.87M shares 10-Q · filed 2026-08-04 | 25.71M shares derived: average of 3 quarters · filed 2026-08-04 | 22.67M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | 13.67M shares 10-Q · filed 2026-05-05 | 13.64M shares derived: average of 2 quarters · filed 2026-05-05 | 13.60M shares derived: average of 3 quarters · filed 2026-05-05 | 13.58M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | 13.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 13.56M shares derived: average of 2 quarters · filed 2026-03-12 | 13.55M shares derived: average of 3 quarters · filed 2026-08-04 | 13.52M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 13.53M shares 10-Q · filed 2025-11-06 | 13.52M shares derived: average of 2 quarters · filed 2026-08-04 | 13.49M shares 10-Q · filed 2025-11-06 | 13.33M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | 13.51M shares 10-Q · filed 2026-08-04 | 13.47M shares 10-Q · filed 2026-08-04 | 13.26M shares derived: average of 3 quarters · filed 2026-08-04 | 10.02M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | 13.42M shares 10-Q · filed 2026-05-05 | 13.13M shares derived: average of 2 quarters · filed 2026-05-05 | 8.86M shares derived: average of 3 quarters · filed 2026-05-05 | 6.72M shares derived: average of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | 12.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 6.58M shares derived: average of 2 quarters · filed 2026-03-12 | 4.49M shares derived: average of 3 quarters · filed 2026-03-12 | 3.45M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 316.14K shares 10-Q · filed 2025-11-06 | 3.34M shares 10-Q · filed 2024-11-07 | 315.81K shares derived: average of 2 quarters · filed 2025-11-06 | 315.21K shares 10-Q · filed 2025-11-06 | 3.34M shares 10-Q · filed 2024-11-07 | -1.71M shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 315.48K shares 10-Q · filed 2025-08-12 | 33.42M shares 10-Q · filed 2024-08-13 | 314.75K shares 10-Q · filed 2025-08-12 | 33.42M shares 10-Q · filed 2024-08-13 | -2.38M shares derived: average of 3 quarters · filed 2025-08-12 | -942.51K shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 314.02K shares 10-Q · filed 2025-05-06 | 33.42M shares 10-Q · filed 2024-05-07 | -3.73M shares derived: average of 2 quarters · filed 2025-05-06 | -1.36M shares derived: average of 3 quarters · filed 2025-05-06 | 6.53M shares derived: average of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -7.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -2.20M shares derived: average of 2 quarters · filed 2025-03-10 | 8.61M shares derived: average of 3 quarters · filed 2025-03-10 | 283.82K shares 10-K · filed 2025-03-10 | 30.68M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 3.38M shares 10-Q · filed 2024-11-07 | 33.81M shares 10-Q · filed 2023-11-13 | 16.80M shares derived: average of 2 quarters · filed 2024-11-07 | 2.97M shares 10-Q · filed 2024-11-07 | 29.72M shares 10-Q · filed 2023-11-13 | 20.80M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 30.22M shares 10-Q · filed 2024-08-13 | 27.64M shares 10-Q · filed 2024-08-13 | 26.61M shares derived: average of 3 quarters · filed 2024-08-13 | 26.08M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 25.04M shares 10-Q · filed 2024-05-07 | 24.80M shares derived: average of 2 quarters · filed 2024-05-07 | 24.70M shares derived: average of 3 quarters · filed 2024-05-07 | 24.64M shares derived: average of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | 24.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 24.53M shares derived: average of 2 quarters · filed 2024-03-28 | 24.51M shares derived: average of 3 quarters · filed 2024-03-28 | 24.50M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 24.50M shares 10-Q · filed 2023-11-13 | 24.48M shares derived: average of 2 quarters · filed 2023-11-13 | 24.47M shares 10-Q · filed 2023-11-13 | 24.48M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 24.46M shares 10-Q · filed 2023-08-10 | 24.46M shares 10-Q · filed 2023-08-10 | 24.47M shares derived: average of 3 quarters · filed 2023-08-10 | 24.45M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 24.46M shares 10-Q · filed 2023-05-11 | 24.48M shares derived: average of 2 quarters · filed 2023-05-11 | 24.45M shares derived: average of 3 quarters · filed 2023-05-11 | 23.68M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 24.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 24.45M shares derived: average of 2 quarters · filed 2023-03-27 | 23.42M shares derived: average of 3 quarters · filed 2023-03-27 | 18.14M shares 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | 24.40M shares 10-Q · filed 2022-11-08 | 22.88M shares derived: average of 2 quarters · filed 2022-11-08 | 16.03M shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 21.36M shares 10-Q · filed 2022-08-09 | 11.77M shares 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | 2.07M shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 2.03M shares 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |